References
- NIH. Cancer Stat Facts: Pancreatic Cancer. Available from:https://seer.cancer.gov/statfacts/html/pancreas.html Accessed 19th September 2023.
- Jung KW, Won YJ, Kang MJ, Kong HJ, Im JS, Seo HG. Prediction of Cancer Incidence and Mortality in Korea. Cancer Res Treat 2022;54(2):345-51. https://doi.org/10.4143/crt.2022.179
- Hong S, Won YJ, Park YR, Jung KW, Kong HJ, Lee ES. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2017. Cancer Res Treat 2020;52(2):335-50. https://doi.org/10.4143/crt.2020.206
- Committee of the Korean clinical practice guideline for pancreatic cancer and National Cancer Center, Korea. Korean clinical practice guideline for pancreatic cancer 2021: A summary of evidence-based, multi-disciplinary diagnostic and therapeutic approaches. Pancreatology 2021;21(7):1326-41. https://doi.org/10.1016/j.pan.2021.05.004
- Conroy T, Desseigne F, Ychou M, Bouche O, Guimbaud R, Becouarn Y, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011;364(19):1817-25. https://doi.org/10.1056/NEJMoa1011923
- Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, et al. Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine. N Engl J Med 2013;369(18):1691-703. https://doi.org/10.1056/NEJMoa1304369
- Han GJ, Jeong HY, Park EJ, Lee AR, Lee JM, Seong S, Kim SS. Review of Domestic Research on Korean Medicine for Pancreatic Cancer. J Int Korean Med 2019;40(1):70-88. https://doi.org/10.22246/jikm.2019.40.1.70
- Ko EB, Jang KJ, Jang JY, Song MH, Shin KS. A Case Report of Partial Remission of End-stage Pancreatic Cancer Patient with Liver Metastasis Treated with Chemotherapy and Integrated Medicine Therapy. J Int Korean Med 2020;41(2):166-76. https://doi.org/10.22246/jikm.2020.41.2.166
- Bang SH, Lee JH, Cho JH, Lee YW, Son CG, Cho CK, et al. A Case Report of Pancreatic Cancer Treated with Lymph Node Metastasis. Korean J Orient Int Med 2007;28(4):948-55.
- Joo HE, Kim JW, Park JH, Cho YM, Seo HS, Ko EJ, et al. A Case Report of Traditional Korean Medicine Based-Integrative Oncology of Recurrent Pancreatic Cancer. J of Kor Traditional Oncology 2022;27(1):1-12.
- Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet 2020;395(10242):2008-20. https://doi.org/10.1016/S0140-6736(20)30974-0
- Yoon HC, Kang JY, Kim JY, Joung JY, Son CG, Lee NH, et al. Trends in Treatment with and Mechanism of Moxibustion in Cancer Patients: A Review. J Int Korean Med 2015;36(3):361-79.
- Guo JQ, Zheng QH, Chen H, Chen L, Xu JB, Chen MY, et al. Ginsenoside Rg3 inhibition of vasculogenic mimicry in pancreatic cancer through downregulation of VE-cadherin/EphA2/MMP9/MMP2 expression. Int J Oncol 2014;45(3):1065-72. https://doi.org/10.3892/ijo.2014.2500
- Bang JY, Kim EY, Shim TK, Yoo HS, Lee YW, Kim YS, et al. Analysis of anti-angiogenic mechanism of HangAmDan-B(HAD-B), a Korean traditional medicine, using antibody microarray chip. J Biochip 2000;4(4):350-5. https://doi.org/10.1007/s13206-010-4412-5
- Kim JM, Park JW, Yoo HS, Lee YW, Cho CK. Case Report of the Pancreatic Cancer Patient after Pancreatoduodenectomy who is Taking the HangAm-Plus to Anti-metastasis and Preventing Recurrence. J of Kor Traditional Oncology 2011;16(1):33-9.
- Bottger F, Valles-Marti A, Cahn L, Jimenez CR. High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer. J Exp Clin Cancer Res 2021;40(1):343.
- Thronicke A, Schad F, Debus M, Grabowski J, Soldner G. Viscum album L. Therapy in Oncology: An Update on Current Evidence. Complement Med Res 2022;29(4):362-8. https://doi.org/10.1159/000524184
- Wei Y, Zhang Y, Li P, Yan C, Wang L. Thymosin α-1 in cancer therapy: Immunoregulation and potential applications. Int Immunopharmacol 2023;117:109744.